RANOZEK 750 MG PROLONGED-RELEASE TABLETS EFG
How to use RANOZEK 750 MG PROLONGED-RELEASE TABLETS EFG
Translated with AI
This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.
Show originalContents of the leaflet
Introduction
Package Leaflet: Information for the Patient
Ranozek 375 mg prolonged-release tablets EFG
Ranozek 500 mg prolonged-release tablets EFG
Ranozek 750 mg prolonged-release tablets EFG
ranolazine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet, you may need to read it again.
- If you have any further questions, ask your doctor, pharmacist, or nurse.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
Contents of the pack
- What is Ranozek and what is it used for
- What you need to know before you take Ranozek
- How to take Ranozek
- Possible side effects
- Storage of Ranozek
- Contents of the pack and other information
1. What is Ranozek and what is it used for
Ranozek is a medicine that is used in combination with other medicines for the treatment of angina pectoris, which is a disease that causes pain in the chest or discomfort that is felt in any part of the upper half of the body between the neck and the upper part of the abdomen, often after physical exercise or a particularly intense activity.
You should consult a doctor if it worsens or does not improve.
2. What you need to know before you take Ranozek
Do not take Ranozek
- if you are allergic to ranolazine or any of the other ingredients of this medicine listed in section 6 of this leaflet.
- if you have severe kidney problems.
- if you have moderate or severe liver problems.
- if you are taking certain medicines for bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazole, posaconazole), HIV infection (AIDS) (protease inhibitors), depression (nefazodone), or heart rhythm disorders (e.g., quinidine, dofetilide, or sotalol).
Warnings and precautions
Consult your doctor before taking this medicine:
- if you have mild or moderate kidney problems.
- if you have mild liver problems.
- if you have ever had an electrocardiogram (ECG) abnormality.
- if you are an elderly person.
- if you are a person of low weight (60 kg or less).
- if you have heart failure.
If you are in any of these situations, your doctor may decide to give you a lower dose of the medicine or take other precautions.
Other medicines and Ranozek
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not use any of the following medicines if you are taking Ranozek:
- certain medicines for bacterial infections (clarithromycin, telithromycin), fungal infections (itraconazole, ketoconazole, voriconazole, posaconazole), HIV infection (AIDS) (protease inhibitors), depression (nefazodone), or heart rhythm disorders (e.g., quinidine, dofetilide, or sotalol).
Tell your doctor or pharmacist before taking this medicine if you are using:
- certain medicines for bacterial infections (erythromycin) or fungal infections (fluconazole), a medicine used to prevent organ rejection after transplantation (cyclosporine), or if you are taking heart pills such as diltiazem or verapamil. These medicines may cause more side effects, such as dizziness, nausea, or vomiting, which are possible side effects of treatment with this medicine (see section 4). If you are taking these medicines, your doctor may decide to give you a lower dose of this medicine.
- medicines for epilepsy or other neurological disorders (e.g., phenytoin, carbamazepine, or phenobarbital); if you are taking rifampicin for tuberculosis; or if you are taking a herbal medicine called St. John's Wort, you should inform your doctor because these medicines may make this medicine less effective.
- heart medicines that contain digoxin or metoprolol, as your doctor may decide to change your dose while taking this medicine.
- certain medicines for allergies (e.g., terfenadine, astemizole, mizolastine), heart rhythm disorders (e.g., disopyramide, procainamide), and medicines for depression (e.g., imipramine, doxepin, amitriptiline), as these medicines may alter your electrocardiogram (ECG).
- certain medicines for depression (bupropion), psychosis, HIV infection (efavirenz), or cancer (cyclophosphamide).
- certain medicines for high cholesterol levels in the blood (e.g., simvastatin, lovastatin, atorvastatin). These medicines may cause muscle pain and damage. Your doctor may decide to change the dose of this medicine while taking this medicine.
- certain medicines used to prevent organ rejection after transplantation (e.g., tacrolimus, cyclosporine, sirolimus, everolimus), so your doctor may decide to change the dose of this medicine while taking this medicine.
Taking Ranozek with food and drinks
This medicine can be taken with or without food. While being treated with this medicine, you should not drink grapefruit juice.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Do not take this medicine if you are pregnant unless your doctor has told you to.
Breastfeeding
Do not take this medicine if you are breastfeeding. Ask your doctor for advice if you are breastfeeding.
Driving and using machines
No studies on the effects of this medicine on the ability to drive and use machines have been performed. Ask your doctor if you can drive or use machines.
This medicine may cause side effects such as dizziness (frequent), blurred vision (uncommon), confusion (uncommon), hallucinations (uncommon), double vision (uncommon), coordination problems (rare), which may affect your ability to drive or use machines. If you experience any of these symptoms, do not drive or use machines until they have passed.
Ranozek contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
3. How to take Ranozek
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
Swallow the tablets whole with water. Do not chew, suck, or crush the tablets, or divide them in half, as this may affect the way the medicine is released into your body.
The initial dose for adults is one 375 mg tablet twice a day. After a period of time between 2 and 4 weeks, your doctor may increase the dose to achieve the desired effect. The maximum dose of this medicine is 750 mg twice a day.
It is important that you inform your doctor if you experience side effects such as dizziness, nausea, or vomiting. Your doctor may reduce the dose or tell you to stop taking the treatment with this medicine.
Use in children and adolescents
Children and adolescents under 18 years should not take this medicine.
If you take more Ranozek than you should
If you accidentally take more tablets of this medicine than you should, or take tablets of a higher dose than recommended by your doctor, it is important that you inform your doctor immediately. If you cannot contact your doctor, go to the nearest emergency center. Take the remaining tablets, along with the blister and packaging, so that the hospital staff can easily see what you have taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Ranozek
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose (less than 6 hours). Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should stop taking this medicine and consult your doctor immediately if you experience the following symptoms of angioedema, which is a rare but serious disorder:
- swelling of the face, tongue, or throat
- difficulty swallowing
- hives or difficulty breathing
Tell your doctor if you experience frequent side effects such as dizziness, nausea, or vomiting. Your doctor may reduce the dose or tell you to stop taking this medicine.
Other side effects you may experience include:
Frequent side effects(may affect up to 1 in 10 people):
Constipation
Dizziness
Headache
Nausea, vomiting
Weakness (asthenia)
Uncommon side effects(may affect up to 1 in 100 people):
Altered sensitivity
Anxiety, difficulty sleeping, confusion, hallucinations
Blurred vision, vision disorders
Sensory disturbances (touch or taste), tremors, fatigue or weakness, somnolence or lethargy, weakness or fainting, dizziness when standing up
Dark urine, blood in the urine, difficulty urinating
Dehydration
Breathing difficulties, cough, nosebleeds
Double vision
Excessive sweating, itching
Feeling of swelling or bloating
Hot flashes, low blood pressure
Increased levels of a substance called creatinine or increased urea in the blood, increased platelet or white blood cell counts in the blood, altered electrocardiogram (ECG)
Swelling of the joints, pain in the limbs
Loss of appetite and/or weight loss
Muscle cramps, muscle weakness
Ringing in the ears and/or feeling of spinning
Stomach pain or discomfort, indigestion, dry mouth, or gas
Rare side effects(may affect up to 1 in 1,000 people):
Urination problems
Abnormal liver laboratory values
Acute kidney failure
Disturbances in the sense of smell, numbness of the mouth or lips, hearing loss
Cold sweat, rash
Coordination problems
Low blood pressure when standing up
Decreased level of consciousness or loss of consciousness
Disorientation
Feeling of cold in hands and feet
Hives, allergic skin reactions
Impotence
Inability to walk due to balance problems
Pancreatitis or intestinal inflammation
Memory loss
Throat tightness
Low sodium levels in the blood (hyponatremia) that can cause fatigue and confusion, muscle contractions, cramps, and coma.
Frequency not known(frequency cannot be estimated from the available data):
Myoclonus
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Ranozek
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
6. Contents of the pack and other information
Composition of Ranozek
The active substance of Ranozek is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg of ranolazine.
The other ingredients are:
Core of the tablet: microcrystalline cellulose (E460), methacrylic acid-ethyl acrylate copolymer (1:1), sodium hydroxide (E524), hypromellose (E464), and magnesium stearate (E470b).
White AquaPolish coating: hypromellose (E464), hydroxypropylcellulose (E463), macrogol 8000 (E1521), and titanium dioxide (E171).
Appearance of the product and pack contents
The 375 mg tablets are white, oval, convex, and have dimensions of 15 mm x 7.2 mm, and are engraved with "375" on one side.
The 500 mg tablets are white, oval, convex, and have dimensions of 16.5 mm x 8.0 mm, and are engraved with "500" on one side.
The 750 mg tablets are white, oval, convex, and have dimensions of 19 mm x 9.2 mm, and are engraved with "750" on one side.
Ranozek is available in boxes containing 30, 60, or 100 tablets in PVC/PVDC-Aluminum blisters.
Not all pack sizes may be marketed.
Marketing authorization holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2ª planta
28023 Madrid
Manufacturer
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
This medicine is authorized in the European Economic Area member states under the following names:
Member state | Medicine name |
Netherlands | Ranozek 375 mg prolonged-release tablets Ranozek 500 mg prolonged-release tablets Ranozek 750 mg prolonged-release tablets |
Germany | Ranozek 375 mg retard tablets Ranozek 500 mg retard tablets Ranozek 750 mg retard tablets |
Latvia | Ranozek 375 mg prolonged-release tablets Ranozek 500 mg prolonged-release tablets Ranozek 750 mg prolonged-release tablets |
Poland | Ranozek |
Italy | Ranozek |
Spain | Ranozek 375 mg prolonged-release tablets EFG Ranozek 500 mg prolonged-release tablets EFG Ranozek 750 mg prolonged-release tablets EFG |
Date of last revision of this leaflet: May 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es.
- Country of registration
- Average pharmacy price41.73 EUR
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to RANOZEK 750 MG PROLONGED-RELEASE TABLETS EFGDosage form: MODIFIED-RELEASE TABLET, 375 mgActive substance: ranolazineManufacturer: Pharmathen S.A.Prescription requiredDosage form: MODIFIED-RELEASE TABLET, 500 mgActive substance: ranolazineManufacturer: Pharmathen S.A.Prescription requiredDosage form: MODIFIED-RELEASE TABLET, 750 mgActive substance: ranolazineManufacturer: Pharmathen S.A.Prescription required
Online doctors for RANOZEK 750 MG PROLONGED-RELEASE TABLETS EFG
Discuss questions about RANOZEK 750 MG PROLONGED-RELEASE TABLETS EFG, including use, safety considerations and prescription review, subject to medical assessment and local regulations.
Frequently Asked Questions